Retraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes

, Frontiers Editorial Office

doi:10.3389/fcvm.2023.1208579

RETRACTION article

Front. Cardiovasc. Med. , 09 May 2023

Sec. Cardiovascular Biologics and Regenerative Medicine

Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1208579

Retraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes

This article is a retraction of:

RETRACTED: STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes
1. Read original article

$\r\nFrontiers Editorial Office \r\n$ Frontiers Editorial Office*

A Retraction of the Original Research Article

STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes

By Joladarashi D, Zhu Y, Willman M, Nash K, Cimini M, Thandavarayan RA, Youker KA, Song X, Ren D, Li J, Kishore R, Krishnamurthy P and Wang L (2022). Front. Cardiovasc. Med. 8:798091. doi: 10.3389/fcvm.2021.798091

The journal retracts the 13 January 2022 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication concerns were identified in Figures 3D, 4E, 6. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Cardiovascular Medicine and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.

Citation: Frontiers Editorial Office (2023) Retraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes. Front. Cardiovasc. Med. 10:1208579. doi: 10.3389/fcvm.2023.1208579

Received: 19 April 2023; Accepted: 19 April 2023;
Published: 9 May 2023.

Approved by: Ngan F Huang, Stanford University, United States

© 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Retraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good